Minerva Surgical, Inc. (UTRS) Q4 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by and welcome to the NERVA's fourth quarter and full year 2022 earnings call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 11 on your telephone. I would now like to hand the call over to Caroline Corner, Investor Relations. Please go ahead. Thank you, Operator. Welcome to Minerva's fourth quarter and full year 2022 earnings call. Joining me on today's call are Todd Yusen, President and Chief Executive Officer, and Jill Young, Chief Financial Officer. This call will provide forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding the markets in which Minerva Surgical operates, trends and expectations for Minerva's products and technology, trends in demand for Minerva's products, Minerva's expected financial performance expenses and position in the market and outlook for fiscal year 2023, and the impact of COVID-19 and its variance on Minerva's operations and Minerva's customers' operations. These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results, performance, or achievements to differ materially from any results, performance, or achievements expressed or implied by the forward-looking statements. Please review Minerva's most recent filings with the SEC for additional information, particularly the risk factors described in Minerva's quarterly report on Form 10-Q for the quarter ended September 30, 2022, whi...